Immunology and Immunotherapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and oncoImmunology. Papers aim to uncover the modulations of the immune system, active and passive immunotherapies, the diagnostic test based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Acute and Chronic Urticaria: New Insights into Pathogenesis, Diagnosis and Therapy (Deadline: 31 October 2023)
- Novel Biomarkers and Mechanisms Underlying HBV and HDV Infection (Deadline: 31 October 2023)
- Emerging Issues in COVID-19 and Neutralizing Antibodies (Deadline: 31 October 2023)
- Editorial Board Members' Collection Series: Immunotherapy (Deadline: 31 October 2023)
- Inflammatory Bowel Diseases: New Diagnostic and Therapeutic Approaches (Deadline: 31 October 2023)
- Immunogenicities and Immunotherapies in Leukemia (Deadline: 31 October 2023)
- New Advance in Immuno-Oncology (Deadline: 31 October 2023)
- Vitamin D in Health and Disease 2.0 (Deadline: 31 October 2023)
- Mechanism and Modulation in Sepsis 2.0 (Deadline: 15 November 2023)
- Macrophages in Health and Non-infectious Disease 4.0 (Deadline: 15 November 2023)
- Stem Cells and Immunomodulation (Deadline: 15 November 2023)
- The Influence of Immunoreaction in Arteriovenous Fistula Maturation and Remolding (Deadline: 30 November 2023)
- Identification and Validation of New Biomarkers to Help the Creation of Clinical Diagnostics in Autoimmune and Cancer Diseases (Deadline: 30 November 2023)
- Trained Immunity and Endotoxin Tolerance in Inflammatory Diseases (Deadline: 30 November 2023)
- COVID Vaccination, Role of Vaccines and Global Health (Deadline: 30 November 2023)
- Advances in Macrophage-Based Immunotherapy (Deadline: 30 November 2023)
- Current Molecular Research on Skin Diseases (Deadline: 30 November 2023)
- Past, Present and Future of COVID-19 2.0 (Deadline: 30 November 2023)
- Recent Advances in Immunotherapy for Solid Tumors (Deadline: 30 November 2023)
- Antioxidant and Anti-inflammatory Agents in Chronic Liver Diseases (Deadline: 30 November 2023)
- Vaccines against Infectious Diseases: Current Research and Future Perspectives (Deadline: 30 November 2023)
- Neutrophils, Fast and Strong 2.0 (Deadline: 30 November 2023)
- Multi-Omics in Cancers and Immune System (Deadline: 15 December 2023)
- The End of the COVID-19 Pandemic—What Is Currently Known and What Could Have Been Useful Four Years Ago? (Deadline: 31 December 2023)
- Basic and Clinical Researches of Antiphospholipid Syndrome (Deadline: 31 December 2023)
- Interactions between Gut Microbiota and Immune System (Deadline: 31 December 2023)
- Advances in Respiratory Allergies (Deadline: 31 December 2023)
- Inflammasome as a Promising Therapeutic Target (Deadline: 31 December 2023)
- Immunomodulatory Potential of Essential Oils and Their Compounds (Deadline: 31 December 2023)
- Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 December 2023)
- State-of-the-Art Immunology and Immunotherapy in Europe (Deadline: 31 December 2023)
- Pathogenesis, Prophylaxis and Treatment of Infectious Diseases (Deadline: 31 December 2023)
- Emerging Viral Infectious Diseases: Immunology, Therapeutics and Prevention in Post Pandemic Era (Deadline: 15 January 2024)
- Cellular Immune Responses in Diseases (Deadline: 15 January 2024)
- Periodontal Inflammation, Periodontal Disease and Systemic Diseases (Deadline: 31 January 2024)
- Photodynamic Therapy 2.0 (Deadline: 31 January 2024)
- Progress in SARS-CoV-2 Vaccines (Deadline: 31 January 2024)
- Inflammation and Immunosenescence in Age-Related Diseases (Deadline: 31 January 2024)
- Immunotherapy for Hepatocellular Carcinoma (Deadline: 31 January 2024)
- Advances in Myocarditis: Molecular and Immune Mechanisms, Diagnosis and Treatment (Deadline: 31 January 2024)
- Sepsis: Pathophysiology and Early Diagnostics (Deadline: 31 January 2024)
- New Advance in Cellular and Molecular Mechanisms of Autoimmune Disease (Deadline: 31 January 2024)
- Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 January 2024)
- Novel Biomarkers and Technologies in the Research and Diagnosis of Human Diseases (Deadline: 29 February 2024)
- Immunosuppressive Signaling Regulation in Cancer Development 2.0 (Deadline: 29 February 2024)
- Pathomechanisms of Disturbances Underlying Chronic Disorders—2nd Edition (Deadline: 29 February 2024)
- Psoriasis- 2 Centuries after Its Discovery: Pathogenesis and Treatment (Deadline: 29 February 2024)
- Emerging Issues in COVID and T Cells (Deadline: 29 February 2024)
- Recent Advances in Biomedicine for Cancer Immunotherapy and Harnessing the Tumor Microenvironment (Deadline: 29 February 2024)
- CAR T-Cell Therapy for AML (Deadline: 29 February 2024)
- Immunotherapy for Pancreatic Cancers (Deadline: 29 February 2024)
- PD-1/PD-L1 and Immunotherapy (Deadline: 29 February 2024)
- The Roles of Circular RNAs in Immune Responses and Immune Diseases (Deadline: 31 March 2024)
- Diagnosis, Pathogenesis and Treatment of TAFRO Syndrome (Deadline: 31 March 2024)
- Pathogenesis and Treatment of Autoimmune and Inflammatory Rheumatic Diseases (Deadline: 31 March 2024)
- The Interplay between Immunity and Microbiota in Human Health and Diseases 2nd Edition (Deadline: 31 March 2024)
- The Role of the Immune System in Kidney Disease: Advances in Mechanisms and Therapeutics (Deadline: 31 March 2024)
- Signaling Networks and Gene Expression in Immune Cells (Deadline: 30 April 2024)
- Oncolytic Viruses and Combinatorial Immunotherapy for Cancer (Deadline: 30 May 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
